Mike Curtis, eGenesis CEO
FDA clears clinical trial of gene-edited pig liver used outside of body
The FDA has permitted eGenesis to begin a clinical trial of a dialysis-like system that involves using a gene-edited pig liver outside of the body …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
